Prognostic Molecular Stratification in Relapsed/Refractory Multiple Myeloma - Results of the Pomalidomide Mukseven (NCT02406222) Biomarker TrialJames Croft, Martin Kaiser, Sidra Ellis et al.|Blood|2019Cited by 4
Molecular Treatment Stratification for Newly Diagnosed High-Risk Myeloma, Including Plasma Cell Leukemia - Feasibility Results of the Ukmra Optimum: MUK9 Trial (NCT03188172)Matthew Jenner, Martin Kaiser, Amy L. Sherborne et al.|Blood|2019Cited by 2